205 related articles for article (PubMed ID: 748042)
1. Mechanism of action of thioureylene antithyroid drugs: factors affecting intrathyroidal metabolism of propylthiouracil and methimazole in rats.
Nakashima T; Taurog A; Riesco G
Endocrinology; 1978 Dec; 103(6):2187-97. PubMed ID: 748042
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of action of thioureylene antithyroid drugs in the rat: possible inactivation of thyroid peroxidase by propylthiouracil.
Shiroozu A; Taurog A; Engler H; Dorris ML
Endocrinology; 1983 Jul; 113(1):362-70. PubMed ID: 6861708
[TBL] [Abstract][Full Text] [Related]
3. A reexamination of the proposed inactivation of thyroid peroxidase in the rat thyroid by propylthiouracil.
Taurog A; Dorris ML
Endocrinology; 1989 Jun; 124(6):3038-42. PubMed ID: 2656250
[TBL] [Abstract][Full Text] [Related]
4. Effects of chronic treatment of intact and hypophysectomized rats with thyroid-stimulating hormone on the metabolism of [35S]methimazole and [35S]propylthiouracil.
Lees JF; Alexander WD
Endocrinology; 1978 Oct; 103(4):1394-400. PubMed ID: 744151
[TBL] [Abstract][Full Text] [Related]
5. Metabolism of 35S- and 14C-labeled propylthiouracil in a model in vitro system containing thyroid peroxidase.
Taurog A; Dorris ML; Guziec FS; Uetrecht JP
Endocrinology; 1989 Jun; 124(6):3030-7. PubMed ID: 2656249
[TBL] [Abstract][Full Text] [Related]
6. Propylthiouracil and methimazole display contrasting pathways of peripheral metabolism in both rat and human.
Taurog A; Dorris ML
Endocrinology; 1988 Feb; 122(2):592-601. PubMed ID: 3338414
[TBL] [Abstract][Full Text] [Related]
7. Metabolism of 35S- and 14C-labeled 1-methyl-2-mercaptoimidazole in vitro and in vivo.
Taurog A; Dorris ML; Guziec FS
Endocrinology; 1989 Jan; 124(1):30-9. PubMed ID: 2535809
[TBL] [Abstract][Full Text] [Related]
8. 35-S-antithyroid drug concentration and organic binding of iodine in the human thyroid.
Lazarus JH; Marchant B; Alexander WD; Clark DH
Clin Endocrinol (Oxf); 1975 Nov; 4(6):609-15. PubMed ID: 53111
[TBL] [Abstract][Full Text] [Related]
9. The mechanism of action of the thioureylene antithyroid drugs.
Taurog A
Endocrinology; 1976 Apr; 98(4):1031-46. PubMed ID: 1278093
[TBL] [Abstract][Full Text] [Related]
10. Effect of antithyroid agents 6-propyl-2-thiouracil and 1-mehtyl-2-mercaptoimidazole on human thyroid iodine peroxidase.
Nagasaka A; Hidaka H
J Clin Endocrinol Metab; 1976 Jul; 43(1):152-8. PubMed ID: 947933
[TBL] [Abstract][Full Text] [Related]
11. Preferential inhibition of thyroxine and 3,5,3'-triiodothyronine formation by propylthiouracil and methylmercaptoimidazole in thyroid peroxidase-catalyzed iodination of thyroglobulin.
Engler H; Taurog A; Dorris ML
Endocrinology; 1982 Jan; 110(1):190-7. PubMed ID: 7053983
[TBL] [Abstract][Full Text] [Related]
12. The placental transfer of propylthiouracil, methimazole and carbimazole.
Marchant B; Brownlie BE; Hart DM; Horton PW; Alexander WD
J Clin Endocrinol Metab; 1977 Dec; 45(6):1187-93. PubMed ID: 591614
[TBL] [Abstract][Full Text] [Related]
13. [Metabolism of thioureylene antithyroid drugs--particularly with relationship between intrathyroidal metabolism of the drugs and the mechanisms of action (author's transl)].
Nakashima T
Rinsho Byori; 1982 Feb; 30(2):170-8. PubMed ID: 6177885
[No Abstract] [Full Text] [Related]
14. Effect of variations in acute and chronic iodine intake on the accumulation and metabolism of [35S]methimazole by the rat thyroid gland. Differences from [35S]propylthiouracil.
Lang JC; Lees JF; Alexander WD; Ingbar SH
Biochem Pharmacol; 1983 Jan; 32(2):241-7. PubMed ID: 6870954
[No Abstract] [Full Text] [Related]
15. Relation between thyroid iodine content and the accumulation and oxidation of [35-S] Methimazole in the rat.
Marchant B; Papapetrou PD; Alexander WD
Endocrinology; 1975 Jul; 97(1):154-61. PubMed ID: 166826
[TBL] [Abstract][Full Text] [Related]
16. Influence of sodium perchlorate on thiourylene antithyroid drug accumulation in mice.
Connell JM; Ferguson MM; Chang DS; Alexander WD
J Endocrinol; 1983 Aug; 98(2):183-7. PubMed ID: 6308122
[TBL] [Abstract][Full Text] [Related]
17. A comparison of potency differences among thyroid peroxidase (TPO) inhibitors to induce developmental toxicity and other thyroid gland-linked toxicities in humans and rats.
Motonaga K; Ota M; Odawara K; Saito S; Welsch F
Regul Toxicol Pharmacol; 2016 Oct; 80():283-90. PubMed ID: 27350053
[TBL] [Abstract][Full Text] [Related]
18. Thyroid Ca2+/NADPH-dependent H2O2 generation is partially inhibited by propylthiouracil and methimazole.
Ferreira AC; de Carvalho Cardoso L; Rosenthal D; de Carvalho DP
Eur J Biochem; 2003 Jun; 270(11):2363-8. PubMed ID: 12755690
[TBL] [Abstract][Full Text] [Related]
19. Role of TSH in the changes in thyroidal metabolism of [35S]methimazole in phenobarbital and thyroxine-treated rats.
Lees JF; Alexander WD; Lewis M; Evered DC
Endocrinology; 1977 Mar; 100(3):765-9. PubMed ID: 401027
[TBL] [Abstract][Full Text] [Related]
20. The selenium analog of methimazole. Measurement of its inhibitory effect on type I 5'-deiodinase and of its antithyroid activity.
Taurog A; Dorris ML; Guziec LJ; Guziec FS
Biochem Pharmacol; 1994 Oct; 48(7):1447-53. PubMed ID: 7524506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
